Check Out The Clinical Stage Company Aiming To Beat Chronic Back Pain!

  • last year
BioRestorative Therapies, Inc. (NASDAQ: BRTX) is currently working on an FDA Phase II clinical trial for their autologous stem-cell therapy, BRTX-100, to help patients who suffer from single-disc-related Chronic Lumbar Degenerative Disc Disease.

Hear from expert, Dr. Jason Lipetz, MD, Physiatrist & Head of Spine Medicine at Northwell Health, as he discusses his work on those trials with BioRestorative Therapies in this must-see interview!

BioRestorative Therapies was founded by scientists committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions.

Recommended

0:45
I
Up next
As Kamala Harris Asian American Voter Engagement Soars in Georgia's Crucial Swing State
Benzinga
0:36
Nearly 60% of U.S. Baby Foods Fail WHO Nutritional Standards. Experts Warn Processed Baby Foods May Harm Child Development.
Benzinga
0:35
Uber And GM's Cruise Partner For Driverless Rides Starting Next Year
Benzinga
15:01
The CEO Of This Innovative BioPharma Is Bringing Light To Cancer Research
Benzinga
0:30
Zoom Stock Soars 13% Following Impressive Q2 Results and Guidance Boost
Benzinga
0:42
Perplexity AI To Run Ads On Search App to Compete with Google and OpenAI
Benzinga
3:46
Brain stimulation therapy could help treat chronic pain
ABC NEWS (Australia)
5:44
Great Home Device To Fix Your Back - Rehydrate Spinal Discs - Heal A Bulging Disc - Posture Pump®
Seeker Land
10:49
Actinium Pharma – Pivotal Results From Key New Drug In The Fight Against Cancer
Benzinga
8:32
Candel Therapeutics (NASDAQ: $CADL): Revolutionizing Glioma Treatment and Redefining Hope
Benzinga
10:14
Unveiling The Potential Of Istaroxime W/ Windtree Therapeutics' SEISMiC Extension Study
Benzinga
9:12
Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
Benzinga
0:41
Stem Cells Treatment May Support Stroke Survivors
HealthFeed
1:31
Scientists Unraveling COVID's Impact on the Brain to Develop New Treatments
Wibbitz Top Stories
1:52
What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?
Benzinga
1:14
$ENLV, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors
Benzinga
5:52
Cancer Patient Physiotherapy Sehatyab Ho Gai - Physiotherapy For Cancer Patients
UrduPoint.com
1:31
Scientists Develop AI-Assisted Blood Test to Detect Parkinson's Before Onset
Wibbitz Top Stories
3:55
Genprex (NASDAQ: GNPX) Releases New Patient Video Interview Describing Positive Experience
Benzinga
11:09
Cognition Therapeutics – Could This Company's Technology Make Debilitating Neural Diseases Like Dementia A Thing Of The Past?
Benzinga
12:29
"Brand New Science" - This Biotech Is Entering Clinical Studies With What It Says Is Novel Science No One Else Has
Benzinga
7:28
This Biotech Is Innovating In Non-Opiod Solutions For Intense Pain
Benzinga
1:50
Analysts Set 12-Month Target Of $15 Per Share For $ENLV Thanks To High Profile Collab. Agreement
Benzinga
17:49
INmune Bio – Helping Your Own Cells Fight Cancer And Reverse Alzheimer's Disease
Benzinga
5:15
Dignity Health - Cancer Institute at St. Joseph’s Hospital on New Treatments for Breast Cancer
CW7 Arizona